|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of intensive glucose lowering in type 2 diabetes显示文摘 | The Action to Control Cardiovascular Risk in Diabetes Study Group | | New England Journal of Medicine0,,: | 6 |
| 2 | Engineering models for catastrophe risk and their application to insurance显示文摘Internationally earthquake insurance, like all other insurance (fire, auto), adopted actuarial approach in the past,which is, based on historical loss experience to determine insurance rate. Due to the fact that earthquake is a rare event withsevere consequence, irrational determination of premium rate and lack of understanding scale of potential loss led to manyinsurance companies insolvent after Northridge earthquake in 1994.Along with recent advances in earth science, computer science and engineering, computerized loss estimation methodologiesbased on first principles have been developed to the point that losses from destructive earthquakes can be quantified withreasonable accuracy using scientific modeling techniques.This paper intends to introduce how engineering models can assist to quantify earthquake risk and how insurance industry can usethis information to manage their risk in the United States and abroad. | Weimin Dong Risk Management Solutions,Inc.USA Ph.D and Visiting Professor of Institute of Engineering Mechanics | 2002 | Earthquake Engineering and Engineering Vibration2002,1,1: | 5 |
| 3 | Quantum dots enhance Cu^(2+)-induced hepatic L02 cells toxicity显示文摘As a new class of xenogenous nanoparticle,quantum dots (QDs) possess the potential to co-exist with Cu2+ in human liver.The combined toxicity is thus concerned.Considering QDs and Cu2+ are known ROS (reactive oxygen species) inducer,we investigated the combined oxidative stress and corresponding protective strategy using human hepatic L02 cells.The results demonstrated that the presence of a small amount of MPA-CdTe QDs (2 μg/mL) in a Cu2+ solution (2.5-20 μg/mL) resulted in a higher toxicity with up to 8-fold cell viability decrease,which was accompanied by cell morphology changes.The combined toxicity was then confirmed as ROS associated oxidative stress with up to 300% and 35% increase of the intracellular ROS level and glutathione S-transferase (GST) activity,respectively.N-acetylcysteine (NAC) can also provide almost complete protection against the induced toxicity.Therefore,the ROS associated oxidant injury might be responsible for the QDs-Cu2+/Cu2+ induced toxicity and could be balanced through cytoprotective antioxidant enzyme GST. | Yuxia Zhao,Kuangfei Lin,Wei Zhang,Lili Liu State Environmental Protection Key Laboratory of Environmental Risk Assessment and Control on Chemical Process,Shanghai 200237,China | 2010 | Journal of Environmental Sciences2010,22,12: | 5 |
| 4 | Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies显示文摘 | The Emerging Risk Factors Collaboration | 2010 | The Lancet2010,,9733: | 3 |
| 5 | Effects of intensive glucose lowering in type 2 diabetes显示文摘 | The Action to Control Cardiovascular Risk in Diabetes Study Group | 2008 | N Engl J Med2008,358,24: | 1 |
| 6 | Quantitative sensory testing can- not dlf-fererhiate simulated sensory loss from sensory neumpathy 显示文摘 | Freeman R Chase KP Risk MR | 2003 | Neurdogy2003,60,: | 1 |
| 7 | Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies 显示文摘 | Emerging risk factors collaboration | 2010 | Lancet2010,375,9733: | 1 |
| 8 | Clinical and Hemiplegic Shoulder Pain: A Longitudinal Observational Study 显示文摘 | Yeo Hyung Kim Sung Jin Jung Sonographic Risk Factors for Eun Joo Yang | 2014 | J Rehabil Med2014,46,: | 1 |
| 9 | Management at high watercuts with anti-agglomerant hydrate inhibitors显示文摘 | Gao Shuqiang Risk Hydrate | 2009 | Energy&Fuels2009,23,: | 1 |
| 10 | The Cancer and Steroid Hormone Study Group显示文摘 | McDivitt RW Stevens JA Lee NC et aL Histologic types of be- nign breast disease and the risk for breast cancer | 1992 | Cancer1992,69,: | 1 |
| 11 | Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies显示文摘 | The Emerging Risk Factors Collaboration | 2010 | The Lancet . 2010 (9733)2010,,9733: | 1 |
| 12 | From Compliance To Value 显示文摘 | Prakash Shimpi Enterprise Risk Management | 2005 | Financial Executive2005,21,6: | 1 |
| 13 | ECPPA (Estudo Colaborativo pare Preveneao da Preeclampsia corn Aspirina) Collaborative Group 显示文摘 | ECPPA : randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women | 1996 | Br J Obstet Gynaecol1996,103,1: | 1 |
| 14 | Tobacco smoke and involuntary smoking 显示文摘 | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans | 2004 | IARC Monogr Eval Carcinog Risks Hum2004,83,: | 1 |
| 15 | Modeling of longitudinally pumped solid state lasers exhibiting reabsorption losses显示文摘 | W P Risk | 1988 | J Opt Soc Am B1988,5,7: | 1 |
| 16 | Lipo-protein ( a) concentration and the risk of coronary heart disease, strokeand nonvascular mortality显示文摘 | Emerging Risk Factors Collaboration Erqou S Kaptoge S | 2009 | JAMA2009,302,4: | 1 |
| 17 | Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy 显示文摘 | Freeman R Chase KP Risk MR | 2003 | Neurology2003,60,3: | 1 |
| 18 | Human papillomaviruses显示文摘 | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans | 2007 | IARC Monographs on the Evaluation of Carcinogenic Risks to Humans/World Health Organization International Agency for Research on Cancer2007,90,1: | 1 |
| 19 | Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines显示文摘 | IARC Working Group on the Evaluation of Carcino- genic Risks to Humans | 2004 | IARC Monogr Eval Carcinog Risks Hum2004,85,: | 1 |
| 20 | The International Neonatal Network 显示文摘 | The CRIB (clinical risk index for babies) score: a tool for asses- sing initial neonatal risk and comparing performance of neonatal intensive care units | 1993 | Lancet1993,342,8865: | 1 |